A Phase 3, Multicenter, Prospective Open-Label Study of the Diagnostic Performance of [18F]FAPI-74 PET/CT for the Detection of Metastatic Disease in Adults with Gastric or Esophageal Cancer (FAPI-GO)

Full Title

A Phase 3, Multicenter, Prospective Open-Label Study of the Diagnostic Performance of [18F]FAPI-74 PET/CT for the Detection of Metastatic Disease in Adults with Gastric or Esophageal Cancer (FAPI-GO) (WCG IRB)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Ali Aria Razmaria’s office at 212-639-7373.

Protocol

26-090

Phase

Phase III (phase 3)

Investigator

Ali Aria Razmaria

Co-Investigators

Yelena Y. Janjigian
Vetri Sudar Jayaprakasam
Vivian E. Strong

Diseases

Upper Gastrointestinal › Esophageal Cancer
Upper Gastrointestinal › Gastric Cancer

Locations

Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau

ClinicalTrials.gov ID

NCT07217704

ClinicalTrials.gov

Visit ClinicalTrials.gov for full clinical trial description